# L_2022182EN.01004301.xml

| 7.7.2022 | EN | Official Journal of the European Union | L 182/43 |
| --- | --- | --- | --- |

7.7.2022

EN

Official Journal of the European Union

L 182/43

---

DECISION OF THE EEA JOINT COMMITTEE No 65/2022

of 18 March 2022

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/1133]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Implementing Decision (EU) 2021/1283 of 2 August 2021 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Implementing Decision (EU) 2021/1283 of 2 August 2021 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement.

| (2) | Commission Implementing Decision (EU) 2021/1285 of 2 August 2021 postponing the expiry date of approval of magnesium phosphide for use in biocidal products of product-type 18 (2) is to be incorporated into the EEA Agreement. |
| --- | --- |

(2)

Commission Implementing Decision (EU) 2021/1285 of 2 August 2021 postponing the expiry date of approval of magnesium phosphide for use in biocidal products of product-type 18 (2) is to be incorporated into the EEA Agreement.

| (3) | Commission Implementing Decision (EU) 2021/1286 of 2 August 2021 postponing the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 (3) is to be incorporated into the EEA Agreement. |
| --- | --- |

(3)

Commission Implementing Decision (EU) 2021/1286 of 2 August 2021 postponing the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 (3) is to be incorporated into the EEA Agreement.

| (4) | Commission Implementing Decision (EU) 2021/1288 of 2 August 2021 postponing the expiry date of approval of boric acid for use in biocidal products of product-type 8 (4) is to be incorporated into the EEA Agreement. |
| --- | --- |

(4)

Commission Implementing Decision (EU) 2021/1288 of 2 August 2021 postponing the expiry date of approval of boric acid for use in biocidal products of product-type 8 (4) is to be incorporated into the EEA Agreement.

| (5) | Commission Implementing Decision (EU) 2021/1289 of 2 August 2021 postponing the expiry date of approval of dazomet for use in biocidal products of product-type 8 (5) is to be incorporated into the EEA Agreement. |
| --- | --- |

(5)

Commission Implementing Decision (EU) 2021/1289 of 2 August 2021 postponing the expiry date of approval of dazomet for use in biocidal products of product-type 8 (5) is to be incorporated into the EEA Agreement.

| (6) | Commission Implementing Decision (EU) 2021/1290 of 2 August 2021 postponing the expiry date of approval of disodium tetraborate for use in biocidal products of product-type 8 (6) is to be incorporated into the EEA Agreement. |
| --- | --- |

(6)

Commission Implementing Decision (EU) 2021/1290 of 2 August 2021 postponing the expiry date of approval of disodium tetraborate for use in biocidal products of product-type 8 (6) is to be incorporated into the EEA Agreement.

| (7) | Commission Implementing Decision (EU) 2021/1299 of 4 August 2021 postponing the expiry date of approval of hexaflumuron for use in biocidal products of product-type 18 (7) is to be incorporated into the EEA Agreement. |
| --- | --- |

(7)

Commission Implementing Decision (EU) 2021/1299 of 4 August 2021 postponing the expiry date of approval of hexaflumuron for use in biocidal products of product-type 18 (7) is to be incorporated into the EEA Agreement.

| (8) | Annex II to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(8)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12zzzzzzzg (Commission Implementing Decision (EU) 2021/1287) of Chapter XV of Annex II to the EEA Agreement:

| ‘12zzzzzzzh. | 32021 D 1283: Commission Implementing Decision (EU) 2021/1283 of 2 August 2021 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 279, 3.8.2021, p. 32). |
| --- | --- |

‘12zzzzzzzh.

32021 D 1283: Commission Implementing Decision (EU) 2021/1283 of 2 August 2021 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 279, 3.8.2021, p. 32).

| 12zzzzzzzi. | 32021 D 1285: Commission Implementing Decision (EU) 2021/1285 of 2 August 2021 postponing the expiry date of approval of magnesium phosphide for use in biocidal products of product-type 18 (OJ L 279, 3.8.2021, p. 37). |
| --- | --- |

12zzzzzzzi.

32021 D 1285: Commission Implementing Decision (EU) 2021/1285 of 2 August 2021 postponing the expiry date of approval of magnesium phosphide for use in biocidal products of product-type 18 (OJ L 279, 3.8.2021, p. 37).

| 12zzzzzzzj. | 32021 D 1286: Commission Implementing Decision (EU) 2021/1286 of 2 August 2021 postponing the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 (OJ L 279, 3.8.2021, p. 39). |
| --- | --- |

12zzzzzzzj.

32021 D 1286: Commission Implementing Decision (EU) 2021/1286 of 2 August 2021 postponing the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 (OJ L 279, 3.8.2021, p. 39).

| 12zzzzzzzk. | 32021 D 1288: Commission Implementing Decision (EU) 2021/1288 of 2 August 2021 postponing the expiry date of approval of boric acid for use in biocidal products of product-type 8 (OJ L 279, 3.8.2021, p. 43). |
| --- | --- |

12zzzzzzzk.

32021 D 1288: Commission Implementing Decision (EU) 2021/1288 of 2 August 2021 postponing the expiry date of approval of boric acid for use in biocidal products of product-type 8 (OJ L 279, 3.8.2021, p. 43).

| 12zzzzzzzl. | 32021 D 1289: Commission Implementing Decision (EU) 2021/1289 of 2 August 2021 postponing the expiry date of approval of dazomet for use in biocidal products of product-type 8 (OJ L 279, 3.8.2021, p. 45). |
| --- | --- |

12zzzzzzzl.

32021 D 1289: Commission Implementing Decision (EU) 2021/1289 of 2 August 2021 postponing the expiry date of approval of dazomet for use in biocidal products of product-type 8 (OJ L 279, 3.8.2021, p. 45).

| 12zzzzzzzm. | 32021 D 1290: Commission Implementing Decision (EU) 2021/1290 of 2 August 2021 postponing the expiry date of approval of disodium tetraborate for use in biocidal products of product-type 8 (OJ L 279, 3.8.2021, p. 47). |
| --- | --- |

12zzzzzzzm.

32021 D 1290: Commission Implementing Decision (EU) 2021/1290 of 2 August 2021 postponing the expiry date of approval of disodium tetraborate for use in biocidal products of product-type 8 (OJ L 279, 3.8.2021, p. 47).

| 12zzzzzzzn. | 32021 D 1299: Commission Implementing Decision (EU) 2021/1299 of 4 August 2021 postponing the expiry date of approval of hexaflumuron for use in biocidal products of product-type 18 (OJ L 282, 5.8.2021, p. 36).’ |
| --- | --- |

12zzzzzzzn.

32021 D 1299: Commission Implementing Decision (EU) 2021/1299 of 4 August 2021 postponing the expiry date of approval of hexaflumuron for use in biocidal products of product-type 18 (OJ L 282, 5.8.2021, p. 36).’

Article 2

The texts of Implementing Decisions (EU) 2021/1283, (EU) 2021/1285, (EU) 2021/1286, (EU) 2021/1288, (EU) 2021/1289, (EU) 2021/1290 and (EU) 2021/1299 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 19 March 2022, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 18 March 2022.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

---

(1)  
  OJ L 279, 3.8.2021, p. 32.

1

(2)  
  OJ L 279, 3.8.2021, p. 37.

2

(3)  
  OJ L 279, 3.8.2021, p. 39.

3

(4)  
  OJ L 279, 3.8.2021, p. 43.

4

(5)  
  OJ L 279, 3.8.2021, p. 45.

5

(6)  
  OJ L 279, 3.8.2021, p. 47.

6

(7)  
  OJ L 282, 5.8.2021, p. 36.

7

(*)  No constitutional requirements indicated.

*

---